Patents-Review.com
🔗 Permalink
Assignee profile:

ARCHIMEDES DEVELOPMENT LIMITED

City:

Nottingham

Country:

United Kingdom

Published Applications:

24

Last publication date:

2013-11-28

Patent Grants:

18

Last grant date:

2017-08-15

Top Inventors for applications by ARCHIMEDES DEVELOPMENT LIMITED

These are the the leading inventors for applications assigned to ARCHIMEDES DEVELOPMENT LIMITED:

Recent patent applications by ARCHIMEDES DEVELOPMENT LIMITED

ARCHIMEDES DEVELOPMENT LIMITED based in Nottingham, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-11-28 ✅ Patent 9,731,869 granted on 2017-08-15
US20130313287A1
Performing operations; transporting

Container

 #2 | 2012-11-01 ✅ Patent 8,889,176 granted on 2014-11-18
US20120277267A1
Human necessities

Method of managing or treating pain

 #3 | 2012-10-25 ✅ Patent 9,078,814 granted on 2015-07-14
US20120270903A1
Human necessities

Intranasal spray device containing pharmaceutical composition

 #4 | 2012-03-08 ✅ Patent 8,915,393 granted on 2014-12-23
US20120055929A1
Performing operations; transporting

Child resistant container

 #5 | 2012-02-02
US20120024724A1
Performing operations; transporting

Medicine Disposal Container

 #6 | 2011-07-28
US20110182857A1
Human necessities

Delivery of Drugs to Mucosal Surfaces

 #7 | 2011-05-05 ✅ Patent 8,491,932 granted on 2013-07-23
US20110104269A1
Human necessities

Compositions for the oral delivery of corticosteroids

 #8 | 2010-10-07 ✅ Patent 8,710,028 granted on 2014-04-29
US20100256091A1
Human necessities

Pharmaceutical powder compositions

 #9 | 2010-09-30 ✅ Patent 8,309,108 granted on 2012-11-13
US20100249170A1
Human necessities

Intranasal compositions

 #10 | 2010-08-12 ✅ Patent 8,709,996 granted on 2014-04-29
US20100203119A1
Human necessities

Pharmaceutical treatment process using chitosan or derivative thereof

 #11 | 2010-02-18
US20100041624A1
Human necessities

Buprenorphine formulations for intranasal delivery

 #12 | 2010-01-28 ✅ Patent 8,481,070 granted on 2013-07-09
US20100021553A1
Human necessities

Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof

 #13 | 2009-09-17 ✅ Patent 8,946,208 granted on 2015-02-03
US20090233912A1
Human necessities

Non-aqueous pharmaceutical composition

 #14 | 2009-05-21 ✅ Patent 8,460,702 granted on 2013-06-11
US20090130202A1
Human necessities

Pharmaceutical compositions

 #15 | 2009-05-07 ✅ Patent 7,838,643 granted on 2010-11-23
US20090118480A1
Chemistry; metallurgy

Quaternary polymers

 #16 | 2008-06-26 ✅ Patent 8,216,604 granted on 2012-07-10
US20080153879A1
Human necessities

Method of managing or treating pain

 #17 | 2008-01-29 ✅ Patent 7,323,183 granted on 2008-01-29
US10141312
-

Vaccine compositions including chitosan for intranasal administration and use thereof

 #18 | 2007-10-04
US20070231269A1
Human necessities

Analgesics

 #19 | 2007-06-21 ✅ Patent 8,034,371 granted on 2011-10-11
US20070140981A1
Human necessities

Intranasal compositions

 #20 | 2007-05-17
US20070110677A1
Human necessities

DELIVERY OF DRUGS TO MUCOSAL SURFACES

 #21 | 2007-04-26
US20070092535A1
Human necessities

DELIVERY OF DRUGS TO MUCOSAL SURFACES

 #22 | 2006-06-08 ✅ Patent 7,662,403 granted on 2010-02-16
US20060120973A1
Human necessities

Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof

 #23 | 2005-06-30 ✅ Patent 7,947,257 granted on 2011-05-24
US20050142073A1
Human necessities

Method of intranasal administration of granisetron

 #24 | 2005-04-21 ✅ Patent 7,666,876 granted on 2010-02-23
US20050085440A1
Human necessities

Buprenorphine formulations for intranasal delivery
AssigneeID:

175287 ⎘